Monday, October 29, 2018 1:58:44 PM
Hexo Corp., a cannabis producer that’s flown under the radar of the pot-stock frenzy, is looking to the Big Apple to get a little more attention.
Hexo is following better known rivals such as Canopy Growth Corp. and Aurora Cannabis Inc. to list shares on the New York Stock Exchange in December. The Gatineau, Quebec-based company, which sees itself as a potential takeover target as it ramps up partnerships with food and cosmetics companies, is betting the listing will attract more global investors.
“It should help tell Hexo’s story as one of the world’s biggest cannabis products makers,” Chief Executive Officer Sebastien St-Louis said in a phone interview. “In five years there may be four global cannabis companies and whether Hexo is a buyer or a seller on that journey, what matters to us is for our shareholders to participate in that to become one of the four.”
With a market value of about $1.1 billion, Hexo is dwarfed by rivals like Canopy and Tilray Inc., which are more than 10 times larger. St-Louis argues the company deserves a higher valuation given its supply contract with the Quebec government, and its joint-venture with Molson Coors Brewing Co. to develop pot-infused beverages. The supply deal with Canada’s second-most populous province is valued at about $1 billion.
In September, investor Riposte Capital published a letter criticizing the company’s “severely depressed valuation,” urging it to consider four options that include selling at a premium or going private.
“The fundamentals for Hexo are incredibly robust and that cannot be said for the majority of their peers,” Khaled Beydoun, Riposte’s managing partner, said in an interview this month. “When you take the fundamentals, and you look at the valuation, the resulting conclusion is there is a huge mispricing.”
Investors have been dumping the shares since Canada legalized pot on Oct. 17, concerned that the surge leading up to legalization left them overpriced. The BI Canada Cannabis Competitive Peers index tumbled 23 per cent between then and Friday’s close. Hexo is the 10th-best performer in the Horizons Marijuana Life Sciences index this year, with a gain of 42 per cent.
St-Louis shrugged off the market volatility, saying some investors cashed in after the steep increase of the past few months. He also said that a lot of Riposte’s suggestions made sense to increase the company’s value -- a change of tone from seven months ago, when his stated goal was to emulate Alimentation Couche-Tard Inc. The convenience-store giant has been gobbling up rivals at home and abroad.
Accept Offer
“It’s certain that if someone comes and offers a 150 per cent premium tomorrow, we are for sale,” said St-Louis, who co-founded the company five years ago and has a stake of almost 2 per cent, according to data compiled by Bloomberg.
St-Louis expects investors to take stock of Hexo’s strengths with its upcoming earnings reports, which will reflect sales in its home province. The five-year supply contract gives it about a third of the legal recreational market.
The company reported revenue of $1.4 million for the quarter ended July 31. Unlike Canopy or Aurora, it doesn’t hold a call with analysts to discuss earnings.
Since a sale could happen “next month or in 10 years,” St-Louis says he’s focused on setting up more joint ventures with partners that could later buy Hexo. Adding patents on cannabis-infused products will make the company more attractive, he said.
“If we keep innovating and adding better products, better ways to consume cannabis without smoking, that intellectual property will keep increasing our value,” he said. “At some point, whether it comes from one of these partners, or from another cannabis company, it’s bound to happen that Hexo will consider an offer.”
Recent HEXO News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/03/2023 08:15:19 PM
- HEXO Corp. Announces Completion of Acquisition by Way of Arrangement With Tilray Brands, Inc. • Business Wire • 06/22/2023 09:02:00 PM
- Tilray Brands Completes Accretive Acquisition of HEXO Corp. Leading the Next Evolution of Canadian Cannabis • GlobeNewswire Inc. • 06/22/2023 09:00:00 PM
- HEXO Corp. Announces Receipt of Final Order for Arrangement With Tilray Brands, Inc. • Business Wire • 06/19/2023 08:06:00 PM
- HEXO Reports Q3’23 Financial Results • Business Wire • 06/14/2023 08:51:00 PM
- Hexo Corp.’s Shareholders Approve Acquisition by Way of Arrangement With Tilray Brands, Inc. • Business Wire • 06/14/2023 04:17:00 PM
- HEXO to Host Third Quarter 2023 Earnings Conference Call • Business Wire • 06/12/2023 09:10:00 PM
- HEXO Announces Closing of Non-Brokered Private Placement and Amendments to Arrangement Agreement and Waiver and Amendment Agreement • Business Wire • 06/01/2023 09:30:00 PM
- Leading Independent Proxy Advisory Firm ISS Recommends HEXO Shareholders Vote FOR the Arrangement Agreement with Tilray Brands • Business Wire • 05/26/2023 11:00:00 AM
- HEXO Corp. Files Circular for Special Meeting of Shareholders to Approve Arrangement With Tilray Brands, Inc. • Business Wire • 05/16/2023 11:00:00 AM
- HEXO Corp. Announces Receipt of Interim Order in Respect of Arrangement With Tilray Brands, Inc. • Business Wire • 05/10/2023 08:45:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM